- Ein abwechslungsreiches Aufgabengebiet, das dich jeden Tag aufs Neue herausfordert
- Flache Hierarchien, kurze Entscheidungswege – bei uns zählt deine Stimme!
- Kostenlose Getränke und ein kostenloser Parkplatz für stressfreie Anfahrten
- #gernperdu
Praktikum für Schüler der FOS (m/ w/ d)
Leipzig
Vollzeit
Praktikum/Werkstudium
Unser Angebot
Deine Aufgaben
- Als Praktikant der FOS erhältst du bei uns abwechslungsreiche Einblicke in den Arbeitsalltag. Die Aufgaben werden soweit möglich an deine Interessen und Stärken angepasst.
Dein Profil
- Schüler der FOS
Kontakt
Hast du Bock, mit uns durchzustarten? Dann freuen wir uns auf deine Bewerbung! Schick uns deinen Lebenslauf, Zeugnisse und ein kurzes Motivationsschreiben an tom.bilgenroth@adragos-pharma.com oder über unser Bewerbungsportal.
About us
Adragos Pharma was founded in 2020 to build a leading global CDMO player in the Small Molecule space. We are pursuing an ambitious Buy&Build growth strategy: within the next three-five years, we will acquire and integrate pharmaceutical production sites in Europe and North America to become a market leader in the CDMO segment.
CDMOs (Contract Development and Manufacturing Organization), produce approx. 25% of drugs that are available in pharmacies and clinics, thus playing a vital role in medication access for millions of patients globally. Due to the increasing pressure on healthcare systems (aging population, prevalence of chronic disease, etc.), the importance of CDMOs is only going to grow.
Since 2020, we grew the team from three to more than 700 people, partnered with Scandinavian PE, FSN Capital, and a leading German Family Office, Prange Group. Until today, we acquired five production and development sites in Germany, France, Greece, Norway and Japan. You want to be part of our dynamic growth? Then apply now!
CDMOs (Contract Development and Manufacturing Organization), produce approx. 25% of drugs that are available in pharmacies and clinics, thus playing a vital role in medication access for millions of patients globally. Due to the increasing pressure on healthcare systems (aging population, prevalence of chronic disease, etc.), the importance of CDMOs is only going to grow.
Since 2020, we grew the team from three to more than 700 people, partnered with Scandinavian PE, FSN Capital, and a leading German Family Office, Prange Group. Until today, we acquired five production and development sites in Germany, France, Greece, Norway and Japan. You want to be part of our dynamic growth? Then apply now!